GlobeNewswire EN Nachrichten

 

The PL-16 Viral Blocker has shown over 90% success in protection of cells against viruses...

Utility-Scale Platform with Indicative US$200-300 Million Project Value and Up To US$360-480 Million in Long-Term Contracted Revenue Potential Utility-Scale Platform with Indicative US$200-300 Million Project Value and Up To US$360-480 Million in Long-Term Contracted Revenue Potential...

PASCAGOULA, Miss., Dec. 19, 2025 (GLOBE NEWSWIRE) -- HII's (NYSE: HII) Ingalls Shipbuilding division has been selected by the U.S. Navy to design and build the future small surface combatant (SSC) ship, leveraging the proven design of the Ingalls-built Legend-class national security cutter (NSC). With a proven track record of building complex ships, and having the available facility capacity, Ingalls shipbuilders will once again engage in construction activities alongside its destroyer and amphibious ship shipbuilding lines where the national security cutters were built, using the same sequence of build....

ISELIN, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced financial results for fiscal year 2025....

Company announcement no. 57 2025...

Dubai and Islamabad, December 19, 2025 – VEON Ltd. (Nasdaq: VEON), a global digital operator, announced today that its financial services subsidiary, Mobilink Microfinance Bank Ltd., has launched Islamic banking operations in Pakistan, expanding access to Shariah-compliant financial services in in response to growing customer demand....

IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager...

BOSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease, today announced the pricing of an underwritten public offering of 35,714,286 shares of its common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof) and accompanying common stock warrants to purchase an aggregate of 17,857,143 shares of common stock. Each share of common stock (or pre-funded warrant to purchase shares of common stock in lieu thereof) and accompanying common stock warrant are being sold together at a combined public offering price of $0.28 (or $0.279, in the case of pre-funded warrants to purchase shares of common stock). The aggregate gross proceeds of the offering are expected to be approximately $10 million, before deducting underwriting discounts and commissions and other offering expens...

Amaero confirming sizable purchase order...

Aduro Clean Technologies priced a US$20M public offering of 1.7M shares plus warrants. Proceeds will fund its Demonstration-Scale Plant...

VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”), is pleased to announce the voting results from its annual general meeting of shareholders (the “Meeting”) held on December 16, 2025....

SINGAPORE, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Ten-League International Holdings Limited (Nasdaq: TLIH) (the “Company” or “Ten-League”), a Singapore-based provider of turnkey project solutions, today announced that it has completed the handover of five hydraulic grabs to Bachy Soletanche Singapore Pte. Ltd. (“Bachy Soletanche Singapore”), a leading provider of geotechnical and foundation engineering solutions in Singapore, in December 2025. The hydraulic grabs are deployed for use in Land Transport Authority's Cross Island Line (“CRL”) project, one of the most significant Mass Rapid Transit (“MRT”) expansions in Singapore....

NORCROSS, Ga., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension, today announced that the U.S. Food and Drug Administration (FDA) has provided a written response, and subsequent communications, to the Company's previously submitted Type C meeting request regarding the development program for belapectin, its investigational galectin-3 inhibitor. The FDA converted the Company's initial request for an in-person or teleconference meeting to a written response....

CAMBRIDGE, Mass., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that its development partner, GSK, filed a New Drug Application (NDA) resubmission to the U.S. Food and Drug Administration (FDA) for tebipenem HBr, an investigational oral carbapenem antibiotic being developed for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis. The NDA submission triggers a $25 million milestone payment to Spero, expected to be received in Q1 2026....

Abacus Global Management Announces Transfer of Listing of its [Class A] Common Stock to the New York Stock Exchange with New Ticker Symbol “ABX”...

New standalone mobile app applies DraftKings' proven technology to event contracts, offering a streamlined experience and expanding the Company's product portfolio New standalone mobile app applies DraftKings' proven technology to event contracts, offering a streamlined experience and expanding the Company's product portfolio...

Management to Reset 2025–2026 Revenue Expectations as Contracted 2026 Revenue Already Exceeds Market Consensus Management to Reset 2025–2026 Revenue Expectations as Contracted 2026 Revenue Already Exceeds Market Consensus...

LONG BEACH, Calif. and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest-growing, vertically-integrated cannabis companies in the U.S., applauds yesterday's cannabis reform action from the Trump administration....

Total national coverage footprint for PENFS increases to roughly 100 million covered lives Total national coverage footprint for PENFS increases to roughly 100 million covered lives...

RONAN, Mont., Dec. 19, 2025 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) ("AirJoule Technologies" or "AIRJ"), a leading technology platform that unleashes the power of water from air, today announced a collaboration with the Red Dot Ranch Foundation (“Red Dot Ranch”) to bring cutting-edge off-grid water solutions to rural communities in coastal California. This positions the AirJoule™ platform technology to address critical water infrastructure gaps while demonstrating the commercial viability of generating pure water from air in real-world residential applications....